The new dopamine receptor agonists are _______ in the treatment of Parkinson's disease.
A) highly effective
B) about as effective as levadopa
C) totally ineffective
D) marginally effective
Correct Answer:
Verified
Q4: At the cellular level,the biological basis for
Q5: The two main COMT-inhibitory drugs talcapone and
Q6: The mainstay of therapy for Parkinson's disease
Q7: MAO-A is associated with _; MAO-B is
Q8: Symptoms of Parkinson's disease are frequently a
Q11: The precursor of levadopa is:
A)dopamine.
B)dopa decarboxylase.
C)tyramine.
D)tyrosine.
Q12: Mainstay drug treatments for Parkinsonism target the
Q13: In your answer above,carbidopa achieves this by
Q14: Undesirable side effects are minimized by combining
Q15: The clinical syndrome of Parkinsonism includes all
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents